BioMarin Pharmaceutical Inc. Share Price Today: Live Updates & Key Insights
BioMarin Pharmaceutical Inc. share price today is $59.33, up 0.78%. The stock opened at $59.24 against the previous close of $58.87, with an intraday high of $59.34 and low of $58.72.
BioMarin Pharmaceutical Inc. Share Price Chart
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. Share Price Performance
BioMarin Pharmaceutical Inc. Institutional Holdings
BioMarin Pharmaceutical Inc. Market Status
BioMarin Pharmaceutical Inc. Fundamentals
Market Cap 11378.65 M
PB Ratio 1.8171
PE Ratio 42.3525
Enterprise Value 10504.98 M
Total Assets 7594.02 M
Volume 1937646
BioMarin Pharmaceutical Inc. Company Financials
About BioMarin Pharmaceutical Inc. & investment objective
Company Information BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme delivered through subcutaneous injection to reduce blood Phe concentrations. It also develops BRINEURA, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; ALDURAZYME, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase; and KUVAN, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria, an inherited metabolic disease. The company's products under development include BMN 333, a longer-acting CNP for the treatment of multiple growth disorders, such as achondroplasia and hypochondroplasia; and BMN 351, an oligonucleotide for the treatment of duchenne muscular dystrophy. It serves specialty pharmacies, hospitals, non-U.S. government agencies, distributors, and pharmaceutical wholesalers. The company has license and collaboration agreements with and Ares Trading S.A. The company was incorporated in 1996 and is based in San Rafael, California.
Organisation Biotechnology
Employees 3221
Industry Biotechnology
CEO Mr. Alexander Hardy
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
BioMarin Pharmaceutical Inc. FAQs
What is the share price of BioMarin Pharmaceutical Inc. today?
The current share price of BioMarin Pharmaceutical Inc. is $59.33.
Can I buy BioMarin Pharmaceutical Inc. shares in India?
Yes, Indian investors can buy BioMarin Pharmaceutical Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy BioMarin Pharmaceutical Inc. shares in India?
You can easily invest in BioMarin Pharmaceutical Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy BioMarin Pharmaceutical Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of BioMarin Pharmaceutical Inc..
Can I buy fractional shares of BioMarin Pharmaceutical Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. has a market cap of $11378.65 M.
In which sector does BioMarin Pharmaceutical Inc. belong?
BioMarin Pharmaceutical Inc. operates in the Biotechnology sector.
What documents are required to invest in BioMarin Pharmaceutical Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of BioMarin Pharmaceutical Inc.?
The PE ratio of BioMarin Pharmaceutical Inc. is 42.35 and the PB ratio is 1.82.